BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 210945)

  • 21. [Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
    Bedenne L; Chauffert B; Lorcerie B; Faivre J; Hillon P; Klepping C; Martin F
    Gastroenterol Clin Biol; 1989 Oct; 13(10):845-6. PubMed ID: 2556316
    [No Abstract]   [Full Text] [Related]  

  • 22. [Selective chemotherapy of hepatocellular carcinomas].
    Keppler D; Pausch J; Gerok W
    Verh Dtsch Ges Inn Med; 1978; (84):606-10. PubMed ID: 217196
    [No Abstract]   [Full Text] [Related]  

  • 23. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma.
    Cochrane AM; Murray-Lyon IM; Brinkley DM; Williams R
    Cancer; 1977 Aug; 40(2):609-14. PubMed ID: 196734
    [No Abstract]   [Full Text] [Related]  

  • 24. 5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
    von Eyben FE; Larsen V; Pedersen H
    Cancer Treat Rep; 1976 Jan; 60(1):29-32. PubMed ID: 1000517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy of large bowel cancer.
    Davis HL
    Cancer; 1982 Dec; 50(11 Suppl):2638-46. PubMed ID: 6215979
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autopsy case of liver cancer undetected until the terminal stage].
    Hattori M; Katsuta K; Hozumi M
    Iryo; 1970 Mar; 24(3):249-55. PubMed ID: 4316183
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro].
    Hasumura S; Nagamori S; Fujise K; Homma S; Sujino H; Matsuura T; Shimizu K; Niiya M; Kameda H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1905-12. PubMed ID: 2543327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of hepatocellular carcinoma with adriamycin. Phase II clinical trial].
    Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
    Gastroenterol Clin Biol; 1984; 8(8-9):679-80. PubMed ID: 6092187
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
    Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of chemotherapeutic agents in the treatment of primary liver cancer].
    Ohya T; Kikuchi S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1623-7. PubMed ID: 6191720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Veronesi A; Magri MD; Trovò MG; Tirelli U; Galligioni E; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Oct; 66(10):1877-8. PubMed ID: 6181871
    [No Abstract]   [Full Text] [Related]  

  • 34. Continuous-infusion doxorubicin in the treatment of primary hepatic malignancies of childhood.
    Neglia JP; Woods WG
    Cancer Treat Rep; 1986 May; 70(5):655-7. PubMed ID: 2423238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II evaluation of doxorubicin plus bleomycin in hepatocellular carcinoma: a Southeastern Cancer Study Group trial.
    Ravry MJ; Omura GA; Bartolucci AA
    Cancer Treat Rep; 1984 Dec; 68(12):1517-8. PubMed ID: 6210143
    [No Abstract]   [Full Text] [Related]  

  • 36. [Should one treat with systemic adriamycin inoperable hepatocellular cancer in cirrhosis?].
    Ballet F; Barbare JC; Petit J; Poupon R; Darnis F
    Gastroenterol Clin Biol; 1982 Mar; 6(3):267-71. PubMed ID: 6284580
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.
    Einhorn LH; Burgess MA; Vallejos C; Bodey GP; Gutterman J; Mavligit G; Hersh EM; Luce JK; Frei E; Freireich EJ; Gottlieb JA
    Cancer Res; 1974 Aug; 34(8):1995-2004. PubMed ID: 4842252
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 39. Vincristine therapy in an infant with probable hepatoblastoma.
    Lascari AD
    Pediatrics; 1970 Jan; 45(1):109-12. PubMed ID: 4312010
    [No Abstract]   [Full Text] [Related]  

  • 40. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
    Han KH; Park JY
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1023-5. PubMed ID: 20594213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.